Authors
Contact Us

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • النتائج
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This paper presents a method of establishing an in vitro psoriasiform cutaneous inflammatory model at the transcription level using a combination of five cytokines (IL-17A, IL-22, IL-1α, TNF-α, OSM) on HaCaT cell line.

Abstract

Psoriasis is a common chronic inflammatory skin disease mediated by innate and adaptive immune systems, characterized by abnormal proliferation and differentiation of epidermal keratinocytes and infiltration of inflammatory cells. Skin-specific keratinocytes are key participants in innate immunity, responding to immune cells and environmental stimulation, thereby serving an important role in the immunopathogenesis of psoriasis. Here, we present a method for inducing psoriasiform keratinocytes inflammation at transcription level with HaCaT cell line using five proinflammatory cytokines combination (M5 combination), including IL-17A, IL-22, IL-1α, TNF-α, and oncostatin M. Results demonstrate that M5 combination induced HaCaT cells showed increased levels of antimicrobial peptides (BD2, S100A7, S100A8, and S100A9), chemokines, and cytokines (CXCL1, CXCL2, CXCL8, CCL20, IL-1β, IL-6 and, IL-18). The mRNA levels of keratinocytes differentiation markers (Keratin1, Keratin10, Filaggrin, and Loricrin) were down regulated, which was consistent with the transcriptome data derived from psoriasis-like keratinocytes. The method described here, therefore, establishes an in vitro psoriasiform cutaneous inflammation at transcription level and contributes to the research for molecular pathogenesis of psoriasis.

Introduction

Psoriasis is a common non-contagious chronic inflammatory skin disease triggered by a dysregulated immune response, affecting the keratinocytes that predominantly form the epidermis1, characterized by abnormally rapid multiplication of keratinocytes with hyperkeratosis and parakeratosis. Psoriasis affects about 3% of the world-wild population2. Disease burden is further increased by several comorbidities, including cardiovascular diseases and metabolic syndrome caused by the syndrome3.

Epidermis is composed of five layers of keratinocytes and undergo morphological change with differentiation process: the stratum basal, stratum spinosum, stratum granulosum, stratum lucidum (found on palms and soles) and stratum corneum described here from the inner to outer surface4. Change in epidermis differentiation leads to a disturbed skin barrier, which is important for the pathogenesis of skin inflammatory diseases5,6,7,8. Keratinocytes play a vital role in maintaining an intact epidermal barrier to prevent water loss and against environmental triggers such as UVB exposure, allergens, and pathogens9. Healthy individuals show a balance between basal cells proliferation and stratum corneum desquamation, while multiple skin diseases including psoriasis, are characterized by an imbalances of this complex mechanism10.

In addition to forming barrier function, keratinocytes are also a critical component of skin's immune system. In the immunopathogeneses of psoriasis, activation of skin-resident Type 1 helper T cells (Th1) and Type 17 helper T cells (Th17), leads to increased production of IFN-γ and IL-17A, respectively. These cytokines induce increased synthesis of chemokines (CCL20, CXCL1/2/8/9/10/11), antimicrobial peptides (BD2, LL37, S100A7/8/9/12), and other inflammatory factors (TNF-α, IL-6, IFN-β) in keratinocytes, leading to the recruitment of more Th1, Th17, and neutrophils into the skin, further amplifying the IL-17/IL23 axis11. The crosstalk between keratinocytes and immune cells is responsible for the induction and maintenance of psoriasis11.

Complex cytokine networks have been described in psoriasis, and the central role of pro-inflammatory cytokines (such as IL-23, IL-22, IL-17, IL-1α, oncostatin M(OSM), and TNF-α) produced by immune cell infiltration has been highlighted12,13. Indeed, previous studies have shown that increased levels of IL-17A, IL-22, IL-1α, TNF-α, and OSM induced a profile of psoriasiform on normal human epidermal keratinocytes in vitro14.

Immortal keratinocyte cell lines (HaCaT) that are more easily obtained and cultured than primary keratinocytes with better reproducibility, have been widely used for the study of psoriasis15,16,17,18,19,20. Different from human papillomavirus16 E6/E7 transformed HEK001 and KerTr cells, HaCaT cell line is capable of expressing differentiation gene products, including Keratin1 (KRT1), Keratin10 (KRT10), Loricrin, and filaggrin20,21,22, thereby providing a promising tool similar to primary keratinocytes to study the regulation of keratinization and proinflammatory.

KRT5/14 is the major type I-type II keratin pair expressed in proliferative basal keratinocytes, whereas differentiated keratinocytes in the suprabasal layers downregulate KRT5/14 and express KRT1/10 as the major keratin pair23. Upon comparison of psoriasis lesion with healthy skin, the changes in keratin expression included decreases in KRT1/1024,25 and increases in KRT5/14 in the psoriatic epidermis26, characterized by hyperproliferation and parakeratosis27. Loricrin is a terminally differentiating structural protein comprising more than 70% of the cornified envelope, contributes to the protective barrier function of the stratum corneum28, down regulated in the skin of psoriasis patients29. Filaggrin is expressed at the final stages of keratinocyte differentiation and is involved in the aggregation of a scaffold-like cornified envelope30, decreased expression in psoriasis lesion skin29.

Overall, our goal was to generate inflammatory keratinocytes model in HaCaT cells using a cytokine combination that will be able to synergistically recapitulate some characteristics of psoriasis skin lesions, including initiating an immune response, keratinocytes proliferation and differentiation.

Protocol

Perform steps 1 to 3 under sterile condition. All the culture medium contained 0.1 mg/mL penicillin and streptomycin.

1. Cell preparation

  1. Seed 1 x 106 HaCaT cells in 10 mL of Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) in 100 mm cell culture dish. Incubate the culture dish at 37 °C in a humidified 5% CO2 incubator for 2 days.
  2. When the culture reaches around 80% confluency, carefully remove the medium from the culture dish and wash the cells with 5 mL of 1x phosphate buffered saline (PBS). Gently rock the culture dish manually.
  3. Remove PBS and add 2 mL of 0.25% trypsin-EDTA solution to the cells. Gently shake the culture dish to let the solution completely coat the monolayer of cells.
  4. Incubate the cells at 37 °C in a humidified 5% CO2 incubator for 5 min until the cells are visibly detached from the surface of the culture dish under phase-contrast microscopy.
    NOTE: The morphology of cells should appear round. If the cells are not well detached, incubate for an additional period of 5 min along with manual agitation.
  5. Once the cells are detached, add 5 mL of DMEM plus 10% FBS to inactivate trypsin and collect the cell suspension in a 50 mL centrifuge tube using a pipette.
  6. Centrifuge the tube containing cell suspension at 180 x g for 5 min. Decant the supernatant.
  7. Add 10 mL of DMEM plus 10% FBS medium to the pellet and gently pipette the medium up and down to bring the cells into suspension.

2. Cell seeding in the 6-well plate

  1. Seed the cells at a density of 2.0 x 105 cells/well in 6-well culture plate.
  2. Incubate the 6-well culture plate at 37 °C in a humidified 5% CO2 incubator overnight before M5 combination stimulation to let the cells adhere to the plate.

3. M5 stimulation of HaCaT cells

  1. Prepare M5 cytokine combination mix medium containing 10 ng/mL of recombinant IL-17A, IL-22, IL-1α, TNF-α, and oncostatin M protein in DMEM containing 2% FBS.
    NOTE: M5 combination consisted of recombination of IL-17A, IL-22, IL-1α, TNF-α, and oncostatin M. Synergistic action of M5 combination recapitulates some features of psoriasis, like upregulation of chemokines and antimicrobial peptides production31.
  2. After overnight cell culture, remove the supernatant, and pipette 2 mL of M5 combination mix medium into each well.
  3. Continue culturing the cells; cell lysates were collected at 24 h for mRNA quantification (step 4) or culture supernatant were collected at 48-72 h for the determination of cytokine levels by ELISA assay32,33,34,35,36,37 (step 6).

4. Harvest mRNA of M5 stimulated HaCaT cells

  1. Aspirate the M5 combination mix medium and wash once with 1-2 mL of cold PBS.
  2. Aspirate PBS and add 1 mL of commercially available guanidium Isothiocyanate solution directly to the culture dish to lyse the cells.
  3. Pipette the lysate up and down several times to homogenize and transfer the cell lysate into a 1.5 mL microcentrifuge tube. Leave at room temperature for 5 min.
  4. Add 200 µL of chloroform, shake the tube vigorously for about 20 s and incubate the sample for 5 min at room temperature.
  5. Centrifuge at 12,000 x g for 10 min at 4 °C.
  6. Transfer the aqueous phase to a fresh 1.5 mL microcentrifuge tube.
  7. Add 500 µL of isopropanol to the aqueous phase and mix gently. Leave at room temperature for 5 min.
  8. Centrifuge at 10,000 x g for 15 min at 4 °C.
  9. Aspirate isopropanol and add 1 mL of 75% ethanol. Wash the pellet once.
  10. Centrifuge at 7,500 x g for 5 min at 4 °C. Pour off the ethanol and let the pellets air-dry.
  11. Add 30 µL DEPC treated water to the RNA pellet. Prepare for RT-PCR detection.

5. Analysis of mRNA expression by Real-Time PCR

  1. Perform cDNA synthesis with 1 µg of total RNA using a commercially available kit following the manufacturer's instruction.
    NOTE: 1 µg of total RNA for SYBR Green RT-PCR assay.
  2. Prepare the PCR reaction mixture. 12.5 µL of SYBR premix EX Taq II, 1µL of PCR Forward Primer (10 µM), 1 µL of PCR Reverse Primer (10 µM), 2 µg of cDNA, and 8.5 µL of dH2O. The final volume is 25 µL per reaction.
    NOTE: List of primer sequences of genes used for RT-PCR analysis in this study is shown in Table 1.
  3. Incubate in thermocycler. The cycling conditions included a denaturing step at 95 °C for 30 s, 40 cycles of 95 °C for 5 s, 60 °C for 30 s, 72°C for 20s and a melting curve analysis.
  4. Analyze RT-PCR experiment data by calculating relative differences in gene expression from Ct (threshold cycle) values using 2-ΔΔCTequations. Use β-actin as an internal control for RT-PCR relative quantitative gene expression standardization.

6. Harvesting cell culture supernatant for ELISA

  1. Pipette each cell culture media into a 1.5 mL microcentrifuge tube.
  2. Centrifuge at 1500 x g for 10 min at 4 °C.
  3. Aliquot the supernatant and store at -80 °C immediately.

7. Analysis of cytokines expression by ELISA

  1. Follow the manufacturer's instruction to prepare all reagents, working standard, and samples. A three-fold serial dilution of standard with sample diluent ranging from 2,000 to 2.74 pg/mL. Dilute samples 1:2 with sample diluent.
  2. Add 100 µL of standard and sample per well. Cover wells with lid and seal the plate with paraffin film. Incubate for 2.5 h at room temperature.
  3. After 2.5 h, discard the solution. Add 300 µL of wash buffer to each well of the plate for 3 min and aspirate. Repeat the process for four additional times. After the last wash, invert the plate and tap on absorbent paper to remove remaining liquid.
  4. Add 100 µL of the detection antibody solution to each well. Incubate the plate on a shaker for 2 h at 37 °C.
    NOTE: Biotinylated detection antibody solution is prepared in each ELISA kits.
  5. Aspirate and wash each well of plate five times using 300 µL of Wash buffer. After the last wash, invert the plate and tap on absorbent paper to remove the remaining liquid.
  6. Add 100 µL of HRP-Streptavidin conjugate to each well. Incubate for 45 min at room temperature with gentle shaking.
  7. Discard the solution by aspirating with a pipette after the incubation. Wash each well of plate five times using 300 µL of Wash buffer. After the last wash, invert the plate and tap on the absorbent paper to remove the remaining liquid.
  8. Perform detection by adding 100 µL of TMB substrate to each well. Incubate for 30 min at 37 °C in the dark.
  9. Add 50 µL of stop solution, when color develops, to each well. Gently tap the plate to ensure thorough mixing. Read at 450 nm immediately.

النتائج

M5 combination stimulation induced inflammatory response of HaCaT cells.
HaCaT cells were stimulated with or without M5 cytokines combination for 24 h. mRNA expression of psoriasis-related genes, which are involved in the regulation of the immune and inflammatory chemokines and antimicrobial peptides, were evaluated. Neutrophil chemokines CXCL138, CXCL239, CXCL840, and...

Discussion

Described herein is a method using five cytokines combination (IL-17A, IL-22, IL-1α, TNF-α, OSM) into HaCaT cell line to establish an in vitro psoriasiform cutaneous inflammation profile at transcription level. This protocol can be adapted for the study on the mechanism of genes in the pathogenesis of psoriasis as well as the screening of therapeutic drugs for psoriasis. Recent reports have shown that overexpression of IL-17A and IL22 producing CD8 T cells in lesional skin suggests their involvement in the path...

Disclosures

No potential conflict of interest was reported by the authors.

Acknowledgements

This work was supported by the National Natural Science Foundation of China [81703132, 31271483, 81472650, 81673061, 81573050, 31872739, and 81601462]

Materials

NameCompanyCatalog NumberComments
DMEM—Dulbecco's Modified Eagle MediumGibco11965092
Fetal Bovine SerumGibco10100139C
HaCaT cellsChina Center for Type CultureCollectionGDC0106Less than 15 generations
Human IL-1β ELISA KitBeyotimePI305
Human IL-6 ELISA KitBeyotimePI330
Human IL-8 ELISA KitBeyotimePI640
IL-1 alpha HumanProspecCYT-253Recombinant protein
IL-17 HumanProspecCYT-250Recombinant protein
IL-22 HumanProspecCYT-328Recombinant protein
OSM HumanProspecCYT-231Recombinant protein
PBSGibco10010049pH 7.4
Penicillin-StreptomycinGibco15140163
PrimeScrip RT reagent KitTAKARARR047A
TB Green Premix Ex TaqTAKARARR420A
TNF alpha HumanProspecCYT-223Recombinant protein
TRIzo ReagentInvitrogen15596018
Trypsin-EDTA (0.25%), phenol redGibco25200072

References

  1. Lowes, M. A., Bowcock, A. M., Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature. 445 (7130), 866-873 (2007).
  2. Gupta, R., Debbaneh, M. G., Liao, W. Genetic epidemiology of psoriasis. Current dermatology reports. 3 (1), 61-78 (2014).
  3. Boehncke, W. -. H., Schön, M. P. Psoriasis. Lancet. 386 (9997), 983-994 (2015).
  4. Zaidi, Z., Lanigan, S. W., Lanigan, W. S., Zaidi, Z. . Dermatology in Clinical Practice. , 1-15 (2010).
  5. Proksch, E., Brandner, J. M., Jensen, J. M. The skin: An indispensable barrier. Experimental Dermatology. 17 (12), 1063-1072 (2008).
  6. Van Smeden, J., Janssens, M., Gooris, G., Bouwstra, J. The important role of stratum corneum lipids for the cutaneous barrier function. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 1841 (3), 295-313 (2014).
  7. Wolf, R., Orion, E., Ruocco, E., Ruocco, V. Abnormal epidermal barrier in the pathogenesis of psoriasis. Clinics in Dermatology. 30 (3), 323-328 (2012).
  8. Proksch, E., Brasch, J. Abnormal epidermal barrier in the pathogenesis of contact dermatitis. Clinics in Dermatology. 30 (3), 335-344 (2012).
  9. Bäsler, K., Brandner, J. M. Tight junctions in skin inflammation. Pflügers Archiv-European Journal of Physiology. 469 (1), 3-14 (2017).
  10. Hoffjan, S., Stemmler, S. On the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasis. British Journal of Dermatology. 157 (3), 441-449 (2007).
  11. Lowes, M. A., Russell, C. B., Martin, D. A., Towne, J. E., Krueger, J. G. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends in Immunology. 34 (4), 174-181 (2013).
  12. Saxena, A., Raychaudhuri, S. K., Raychaudhuri, S. P. . Psoriatic Arthritis and Psoriasis. , 73-82 (2016).
  13. Lowes, M. A., Suárez-Fariñas, M., Krueger, J. G. Immunology of psoriasis. Annual Review of Immunology. 32, 227-255 (2014).
  14. Guilloteau, K., et al. Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α recapitulates some features of psoriasis. The Journal of Immunology. 184 (9), 5263-5270 (2010).
  15. Wang, Z., et al. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation. Autophagy. , 1-24 (2020).
  16. Choi, D. H., Hwang, H. S. Anti-inflammation activity of brazilin in TNF-α induced human psoriasis dermatitis skin model. Applied Biological Chemistry. 62 (1), 46 (2019).
  17. Teng, X., et al. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. Journal of Immunology. 192 (4), 1815-1823 (2014).
  18. Wu, S., et al. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model. Life Sciences. 241, 117115 (2020).
  19. Katarzyna, B., Elwira, S., Marta, M., Joanna, J. -. B., Magdalena, G. -. C. Models in the Research Process of Psoriasis. International Journal of Molecular Ences. 18 (12), 2514 (2017).
  20. Auewarakul, P., Gissmann, L., Cid-Arregui, A. Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors. Molecular and Cellular Biology. 14 (12), 8250-8258 (1994).
  21. Boukamp, P., et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. Journal of Cell Biology. 106 (3), 761-771 (1988).
  22. Irma, C., et al. HaCaT cells as a reliable in vitro differentiation model to dissect the inflammatory/repair response of human keratinocytes. Mediators of Inflammation. 2017, 7435621 (2017).
  23. Melino, G., et al. The cornified envelope: a model of cell death in the skin. Results & Problems in Cell Differentiation. 24 (4), 175 (1998).
  24. Thewes, M., Stadler, R., Mischke, B. K. Normal psoriatic epidermis expression of hyperproliferation-associated keratins. Archives of Dermatological Research. , (1991).
  25. Ishida-Yamamoto, A., Senshu, T., Takahashi, H., Akiyama, K., Iizuka, H. Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis. Journal of investigative Dermatology. 114 (4), 701-705 (2000).
  26. Elango, T., et al. Methotrexate normalized keratinocyte activation cycle by overturning abnormal keratins as well as deregulated inflammatory mediators in psoriatic patients. Clinica Chimica Acta. , 329-337 (2015).
  27. Ghadially, R., Reed, J. T., Elias, P. M. Stratum corneum structure and function correlates with phenotype in psoriasis. Journal of investigative dermatology. 107 (4), 558-564 (1996).
  28. Nithya, S., Radhika, T., Jeddy, N. Loricrin - An overview. Journal of Oral and Maxillofacial Pathology. 19 (1), (2015).
  29. Kim, B. E., et al. TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal Kinase: Role for TNF-α antagonists to improve skin barrier. Journal of Allergy & Clinical Immunology. 127 (2), (2011).
  30. Gutowska-Owsiak, D., et al. IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion. Experimental dermatology. 21 (2), 104-110 (2012).
  31. Guilloteau, K., et al. Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α recapitulates some features of psoriasis. Journal of Immunology. 184 (9), 5263-5270 (2010).
  32. Jeon, B., et al. Optimization and validation of a method to identify skin sensitization hazards using IL-1 α and IL-6 secretion from HaCaT. Toxicology In Vitro : An International Journal Published in Association with BIBRA. 61, 104589 (2019).
  33. Lee, K. -. M., Kang, J. H., Yun, M., Lee, S. -. B. Quercetin inhibits the poly(dA:dT)-induced secretion of IL-18 via down-regulation of the expressions of AIM2 and pro-caspase-1 by inhibiting the JAK2/STAT1 pathway in IFN-γ-primed human keratinocytes. Biochemical and Biophysical Research Communications. 503 (1), 116-122 (2018).
  34. Lee, N., Chung, Y. C., Kang, C. I., Park, S. -. M., Hyun, C. -. G. 7,8-dimethoxycoumarin attenuates the expression of IL-6, IL-8, and CCL2/MCP-1 in TNF-α-treated HaCaT cells by potentially targeting the NF-κB and MAPK pathways. Cosmetics. 6 (3), (2019).
  35. Smolińska, E., Moskot, M., Jakóbkiewicz-Banecka, J., Wgrzyn, G., Gabig-Cimińska, M. Molecular action of isoflavone genistein in the human epithelial cell line HaCaT. PLoS One. 13 (2), 0192297 (2018).
  36. Ying, X., Yan, Y., Li, Y. Tripterine alleviates LPS-induced inflammatory injury by up-regulation of miR-146a in HaCaT cells. Biomedicine & Pharmacotherapy. 105, 798 (2018).
  37. Zhang, M., et al. AIM2 inflammasome mediates Arsenic-induced secretion of IL-1 β and IL-18. Oncoimmunology. 5 (6), 1160182 (2016).
  38. Lowes, M. A., et al. Immunology of Psoriasis. Annual Review of Immunology. 32, 227-255 (2014).
  39. Nedoszytko, B., Wojdyło, M. S., Dziurdzińska, K. -. S., Roszkiewicz, J., Nowicki, R. J. Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis. Postepy Dermatologii i Alergologii. 31, 84-91 (2014).
  40. Glowacka, E., Lewkowicz, P., Rotsztejn, H., Zalewska, A. IL-8, IL-12 and IL-10 cytokines generation by neutrophils, fibroblasts and neutrophils- fibroblasts interaction in psoriasis. Advances in Medical Sciences. 55 (2), 254-260 (2010).
  41. Li, H., et al. Cyr61/CCN1 induces CCL20 production by keratinocyte via activating p38 and JNK/AP-1 pathway in psoriasis. Journal of Dermatological Science. 88 (1), 46-56 (2017).
  42. Kim, T. G., et al. Dermal clusters of mature dendritic cells and T cells are associated with the CCL20/CCR6 chemokine system in chronic psoriasis. Journal of Investigative Dermatology. 134 (5), 1462-1465 (2014).
  43. Kolbinger, F., et al. β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis. The Journal of Allergy and Clinical Immunology. 139 (3), (2017).
  44. Ekman, A., Vegfors, J., Eding, C., Enerbäck, C. Overexpression of psoriasin (S100A7) contributes to dysregulated differentiation in psoriasis. Acta Dermato-Venereologica. 97 (4), 441-448 (2016).
  45. Peric, M., et al. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "Alarmins" psoriasin (S100A7) and Koebnerisin (S100A15) in psoriasis. Journal of Investigative Dermatology. 132 (5), 1416-1424 (2012).
  46. Aochi, S., et al. Markedly elevated serum levels of calcium-binding S100A8/A9 proteins in psoriatic arthritis are due to activated monocytes/macrophages. Journal of the American Academy of Dermatology. 64 (5), 879-887 (2011).
  47. Krueger, J. G., et al. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. Journal of Allergy Clinical Immunology. 130 (1), 145-154 (2012).
  48. Wilsmann-Theis, D., et al. Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity. Journal of the European Academy of Dermatology & Venereology. 30 (7), 1165-1170 (2016).
  49. Wang, Z., et al. Systematic screening and identification of novel psoriasis-specific genes from the transcriptome of psoriasis-like keratinocytes. Molecular Medicine Reports. 19 (3), 1529-1542 (2018).
  50. Mizutani, H., Ohmoto, Y., Mizutani, T., Murata, M., Shimizu, M. Role of increased production of monocytes TNF-alpha, IL-1beta and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments. Journal of dermatological science. 14 (2), 145-153 (1997).
  51. Pietrzak, A., Lecewicz-Torun, B., Chodorowska, G., Rolinski, J. Interleukin-18 levels in the plasma of psoriatic patients correlate with the extent of skin lesions and the PASI score. Acta Dermato-Venereologica. 83 (4), 262-265 (2003).
  52. Cai, Y., et al. A critical role of the IL-1β-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. Journal of investigative Dermatology. 139 (1), 146-156 (2018).
  53. Arican, O., Aral, M., Sasmaz, S., Ciragil, P. Serum levels of TNF-α, IFN-γ IL-6, IL-8,IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators of Inflammation. 2005 (5), 273-279 (2005).
  54. Grossman, R. M., et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proceedings of the National Academy of Sciences of the United States of America. 86 (16), 6367-6371 (1989).
  55. Nair, R. P., et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nature Genetics. 41 (2), 199-204 (2009).
  56. Boukamp, P., et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. The Journal of Cell Biology. 106 (3), 761-771 (1988).
  57. Deyrieux, A. F., Wilson, V. G. In vitro culture conditions to study keratinocyte differentiation using the HaCaT cell line. Cytotechnology. 54 (2), 77-83 (2007).
  58. Micallef, L., et al. Effects of extracellular calcium on the growth-differentiation switch in immortalized keratinocyte HaCaT cells compared with normal human keratinocytes. Experimental Dermatology. 18 (2), 143-151 (2009).
  59. Wilson, V. G. . Epidermal Cells. , 33-41 (2013).
  60. Ding, J., et al. Gene expression in skin and lymphoblastoid cells: Refined statistical method reveals extensive overlap in cis-eQTL signals. American Journal of Human Genetics. 87 (6), 779-789 (2010).
  61. Res, P. C., et al. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One. 5 (11), (2010).
  62. Groves, R. W., Mizutani, H., Kieffer, J. D., Kupper, T. S. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proceedings of the National Academy of Sciences. 92 (25), 11874-11878 (1995).
  63. Chan, J. R., et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. The Journal of Experimental Medicine. 203 (12), 2577-2587 (2006).
  64. Zheng, Y., et al. Interleukin-22, a TH 17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 445 (7128), 648-651 (2007).
  65. Ma, H. -. L., et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. The Journal of Clinical Investigation. 118 (2), 597-607 (2008).
  66. Lowes, M. A., Russell, C. B., Martin, D. A., Towne, J. E., Krueger, J. G. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol. 34 (4), 174-181 (2013).
  67. Banno, T., Gazel, A., Blumenberg, M. Effects of tumor necrosis factor-α (TNFα) in epidermal keratinocytes revealed using global transcriptional profiling. Journal of Biological Chemistry. 279 (31), 32633-32642 (2004).
  68. Boniface, K., et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. The Journal of Immunology. 174 (6), 3695-3702 (2005).
  69. Boniface, K., et al. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. The Journal of Immunology. 178 (7), 4615-4622 (2007).
  70. Terui, T. Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: A neutrophil-associated inflammation-boosting loop. Experimental Dermatology. 9, (2000).
  71. Chiang, C. -. C., Cheng, W. -. J., Korinek, M., Lin, C. -. Y., Hwang, T. -. L. Neutrophils in psoriasis. Frontiers in Immunology. 10, 2376 (2019).
  72. Kennedy-Crispin, M., et al. Human keratinocytes' response to injury upregulates CCL20 and other genes linking innate and adaptive immunity. The Journal of Investigative Dermatology. 132 (1), 105-113 (2012).
  73. Morizane, S., Gallo, R. L. Antimicrobial peptides in the pathogenesis of psoriasis. The Journal of Dermatology. 39 (3), 225-230 (2012).
  74. Vandal, K., et al. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. The Journal of Immunology. 171 (5), 2602-2609 (2003).
  75. Ryckman, C., Vandal, K., Rouleau, P., Talbot, M., Tessier, P. A. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. The Journal of Immunology. 170 (6), 3233-3242 (2003).
  76. Nukui, T., et al. S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. Journal of Cellular Biochemistry. 104 (2), 453-464 (2008).
  77. Yang, D., et al. β-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 286 (5439), 525-528 (1999).
  78. Hsu, K., et al. Anti-infective protective properties of S100 calgranulins. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents). 8 (4), 290-305 (2009).
  79. Nestle, F. O., Kaplan, D. H., Barker, J. Psoriasis. The New England journal of medicine. 361 (5), 496-509 (2009).
  80. Tsoi, L. C., et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nature Genetics. 44 (12), 1341 (2012).
  81. Swindell, W. R., et al. RNA-seq identifies a diminished differentiation gene signature in primary monolayer keratinocytes grown from lesional and uninvolved psoriatic skin. Scientific Reports. 7 (1), 1-13 (2017).
  82. Candi, E., Schmidt, R., Melino, G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol. 10 (4), 328-340 (2005).
  83. Frost, P., Weinstein, G. D., Van Scott, E. J. The ichthyosiform dermatoses II. Journal of Investigative Dermatology. 47, 561-567 (1966).
  84. Reichelt, J., Furstenberger, G., Magin, T. M. Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice. Journal of Investigative Dermatology. 123 (5), 973-981 (2004).
  85. Hu, Z., et al. Loss-of-function mutations in filaggrin gene associate with psoriasis vulgaris in Chinese population. Human Genetics. 131 (7), 1269-1274 (2012).
  86. Giardina, E., et al. Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Annals of Human Genetics. 68 (6), 639-645 (2004).
  87. Suga, H., et al. Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma. Clinical Cancer Research. 20 (16), 4339-4348 (2014).
  88. Iotzova-Weiss, G., et al. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products. PLoS One. 10 (3), (2015).
  89. Seo, M. -. D., Kang, T. J., Lee, C. H., Lee, A. -. Y., Noh, M. HaCaT keratinocytes and primary epidermal keratinocytes have different transcriptional profiles of cornified envelope-associated genes to T helper cell cytokines. Biomolecules & Therapeutics. 20 (2), 171-176 (2012).
  90. Soboleva, A. G., et al. Genetically predetermined limitation in the use of HaCaT cells that affects their ability to serve as an experimental model of psoriasis. Genetika. 50 (10), 1222-1231 (2014).
  91. Wang, Z., et al. Systematic screening and identification of novel psoriasis-specific genes from the transcriptome of psoriasis-like keratinocytes. Molecular Medicine Reports. 19 (3), 1529-1542 (2019).
  92. Inoue, K., et al. Mechanism underlying ATP release in human epidermal keratinocytes. The Journal of Investigative Dermatology. 134 (5), 1465-1468 (2014).
  93. Harden, J. L., et al. CARD14 expression in dermal endothelial cells in psoriasis. PLoS One. 9 (11), 111255 (2014).
  94. Krueger, J. G., et al. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. The Journal of Allergy and Clinical Immunology. 130 (1), (2012).
  95. Hegyi, Z., et al. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. The Journal of Investigative Dermatology. 132 (5), 1416-1424 (2012).
  96. Schonthaler, H. B., et al. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity. 39 (6), 1171-1181 (2013).
  97. Wilsmann-Theis, D., et al. Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity. Journal of the European Academy of Dermatology and Venereology : JEADV. 30 (7), 1165-1170 (2016).
  98. Leuner, K., et al. Reduced TRPC channel expression in psoriatic keratinocytes is associated with impaired differentiation and enhanced proliferation. PLoS One. 6 (2), 14716 (2011).
  99. Gao, L., et al. Ozone therapy promotes the differentiation of basal keratinocytes via increasing Tp63-mediated transcription of KRT10 to improve psoriasis. Journal of Cellular and Molecular Medicine. 24 (8), 4819-4829 (2020).
  100. Kim, B. E., et al. TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier. The Journal of Investigative Dermatology. 131 (6), 1272-1279 (2011).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Transcription ProfilePsoriasiformHaCaT CellsCytokinesPsoriasisKeratinocytesInflammationAntimicrobial PeptidesChemokinesCytokinesDifferentiation MarkersTranscriptome DataMolecular Pathogenesis

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Contact Us

Recommend to library

JoVE NEWSLETTERS

Research

Education

Authors

Librarians

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved